Shandong Lukang PharmaceuticalLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Kun Dong
Chief executive officer
CN¥1.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4yrs |
| CEO ownership | 0.06% |
| Management average tenure | 4.4yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
We Think Shandong Lukang PharmaceuticalLtd (SHSE:600789) Is Taking Some Risk With Its Debt
Jan 16
A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb
Nov 11We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings
Nov 05Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?
Sep 26Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings
Aug 21Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?
Jun 03Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement
May 06Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals
Apr 03CEO
Kun Dong (54 yo)
4yrs
Tenure
CN¥1,130,400
Compensation
Mr. Kun Dong is General Manager and Director at Shandong Lukang Pharmaceutical Co.,Ltd since May 19, 2021. He was Deputy General Manager of Shandong Lukang Pharmaceutical Co.,Ltd.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4yrs | CN¥1.13m | 0.057% CN¥ 5.6m | |
| Deputy General Manager | 4.8yrs | CN¥902.60k | 0.022% CN¥ 2.2m | |
| Deputy General Manager | 4.8yrs | CN¥889.40k | 0.022% CN¥ 2.2m | |
| Finance Director & Director | 1.1yrs | no data | no data |
4.4yrs
Average Tenure
45yo
Average Age
Experienced Management: 600789's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4yrs | CN¥1.13m | 0.057% CN¥ 5.6m | |
| Finance Director & Director | 1.1yrs | no data | no data | |
| Director | 3yrs | no data | no data | |
| Chairman | 7yrs | CN¥1.37m | 0.096% CN¥ 9.4m | |
| Director | 1.1yrs | CN¥873.30k | 0.057% CN¥ 5.6m | |
| Director | 1.1yrs | no data | no data | |
| Independent Director | 4yrs | CN¥100.00k | no data | |
| Independent Director | 4yrs | CN¥100.00k | no data | |
| Independent Director | 4yrs | no data | no data | |
| Employee Representative Supervisor | 6yrs | no data | no data |
4.0yrs
Average Tenure
52yo
Average Age
Experienced Board: 600789's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 15:43 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Lukang Pharmaceutical Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.